ReviewPoultry science2026
Antimicrobial-resistant Escherichia Coli and Salmonella in poultry production and spread and effect in the one health framework.
Review in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Self-Assembled Carrier-Free Nanostructures of Anemoside B4 and Oleanolic Acid Alleviate Intestinal Injury Induced by IntraperitonealAntioxidants (Basel, Switzerland) · 2026Article
- Identification and protective efficacy characterization of novel immunogenic antigens for Salmonella Enteritidis vaccines.Poultry science · 2026Article
- Phenotypic Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2026Article
- Phenotypic and Genomic Characterization of Novel Straboviridae Bacteriophages Targeting Multidrug-ResistantMicroorganisms · 2026Article
- Antimicrobial use and resistance profiles of Escherichia coli and Campylobacter species from small-scale poultry farms in Central Kenya.BMC veterinary research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance in poultry-associated Escherichia coli and Salmonella poses a significant threat to animal, food, and public health, particularly when viewed through the One Health framework. Consider the statistics: global data reveal substantial resistance to tetracyclines (45-92 %), aminopenicillins (38-85 %), sulfonamides (40-78 %), and fluoroquinolones (25-68 %). Additionally, a considerable proportion of isolates (32-74 %) exhibit multidrug resistance. However, the manifestation of this resistance varies widely both between and within countries, influenced by factors such as antimicrobial usage, production scale, biosecurity measures, and the rigor of regulations and surveillance. Notably, the two primary Salmonella serovars-Salmonella Typhimurium and S. Enteritidis, along with increasingly prevalent avian pathogenic E. coli strains, reflect a complex ecological and evolutionary resistance profile characterized by persistence and transmission. Variability in study design, breakpoint criteria, and the use of phenotypic versus genotypic methods contribute to inconsistent findings. Furthermore, geographical differences and limited genomic data hinder accurate estimation of the global burden of antimicrobial resistance. The evolution of resistance occurs through multiple pathways. In high-income countries, robust stewardship programs result in a resistance profile that differs significantly from those in low- and middle-income countries, where antimicrobial use is often less regulated, veterinary services are limited, and prophylactic antimicrobial use is more common. However, resistance is not confined to farms; environmental dissemination through manure, processing, and interspecies transmission of resistance genes to other microbes all contribute to the spread of resistance beyond the farm gate. To address this issue, it is essential to harmonize surveillance systems, improve governance, carefully monitor antimicrobial use, and rationalize economic incentives to achieve stewardship objectives. This includes investing in vaccine development, biosecurity measures, and environmental interventions to reduce the initial need for antimicrobial use. Without a coordinated approach across the entire poultry production chain, poultry will continue to serve as a significant reservoir and vector for the transmission of zoonotic antimicrobial-resistant bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.